Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Obstructive Lung Diseases

  Free Subscription


11.03.2019

2 Allergy
10 Ann Allergy Asthma Immunol
1 Arerugi
1 BMJ
1 Clin Exp Allergy
8 Eur Respir J
1 J Allergy Clin Immunol
1 J Appl Physiol (1985)
1 J Asthma
2 J Pediatr
4 Lancet Respir Med
4 PLoS One
3 Respir Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Allergy

  1. RUSSKAMP D, Aguilar-Pimentel A, Alessandrini F, Gailus-Durner V, et al
    IL-4 receptor alpha blockade prevents sensitization and alters acute and long-lasting effects of allergen-specific immunotherapy of murine allergic asthma.
    Allergy. 2019 Mar 4. doi: 10.1111/all.13759.
    PubMed     Text format     Abstract available

  2. KUO HC, Lo CC, Wang YD, Wu JD, et al
    Spectrogram for Childhood Asthma Detection and Analysis.
    Allergy. 2019 Mar 6. doi: 10.1111/all.13768.
    PubMed     Text format    


    Ann Allergy Asthma Immunol

  3. DINAKAR C, Fineman SM, Chipps BE, Khan DA, et al
    From the pages of allergywatch recent advances in our understanding of the environment's role in allergy.
    Ann Allergy Asthma Immunol. 2018 Mar 22. pii: S1081-1206(18)30223.
    PubMed     Text format    

  4. OLAND A, Booster GD, Bender BG
    Integrated behavioral health care for management of stress in allergic diseases.
    Ann Allergy Asthma Immunol. 2018 May 8. pii: S1081-1206(18)30335.
    PubMed     Text format     Abstract available

  5. FINEMAN SM, Khan DA, Dinakar C, Lang DM, et al
    From the pages of allergywatch July 2018.
    Ann Allergy Asthma Immunol. 2018 May 16. pii: S1081-1206(18)30374.
    PubMed     Text format    

  6. TURCOTTE DA, Woskie S, Gore R, Chaves E, et al
    Asthma, Copd And Home Environments: Interventions With Older Adults.
    Ann Allergy Asthma Immunol. 2019 Mar 1. pii: S1081-1206(19)30142.
    PubMed     Text format    

  7. JIANG D, Wang Z, Shen C, Jin C, et al
    Small airway dysfunction may be an indicator of early asthma: findings from high-resolution CT.
    Ann Allergy Asthma Immunol. 2019 Mar 1. pii: S1081-1206(19)30140.
    PubMed     Text format    

  8. BENJAMIN MR, Bochner BS, Peters AT
    Mepolizumab use: Post-approval academic practice experience.
    Ann Allergy Asthma Immunol. 2018;121:126-128.
    PubMed     Text format    

  9. PERINO E, Freymond N, Devouassoux G, Nicolas JF, et al
    Xolair(R)-induced recurrent anaphylaxis through sensitization to the excipient polysorbate.
    Ann Allergy Asthma Immunol. 2018 Feb 23. pii: S1081-1206(18)30145.
    PubMed     Text format    

  10. IZADI N, Brar KK, Lanser BJ
    Evaporative coolers are not associated with dust mite or mold sensitization in a large pediatric cohort.
    Ann Allergy Asthma Immunol. 2018;120:542-543.
    PubMed     Text format    

  11. RABINOVITCH N, Leung DYM, Covar R
    The highs and lows of marijuana use in allergy.
    Ann Allergy Asthma Immunol. 2018 Feb 13. pii: S1081-1206(18)30120.
    PubMed     Text format    

  12. PATEL NP, Prizment AE, Thyagarajan B, Roberts E, et al
    Urban versus Rural Residency and Allergy Prevalence among Adult Women: Iowa Women's Health Study.
    Ann Allergy Asthma Immunol. 2018 Apr 6. pii: S1081-1206(18)30251.
    PubMed     Text format     Abstract available


    Arerugi



  13. Arerugi. 2018;67:153-154.
    PubMed     Text format    


    BMJ

  14. JOLLY K, Sidhu MS, Hewitt CA, Coventry PA, et al
    Self management of patients with mild COPD in primary care: randomised controlled trial.
    BMJ. 2018;361:k2241.
    PubMed     Text format     Abstract available


    Clin Exp Allergy

  15. JOHANSSON E, Biagini Myers JM, Martin LJ, He H, et al
    Identification of two early life eczema and non-eczema phenotypes with high risk for asthma development.
    Clin Exp Allergy. 2019 Mar 4. doi: 10.1111/cea.13379.
    PubMed     Text format     Abstract available


    Eur Respir J

  16. BEAUMONT M, Mialon P, Le Ber C, Le Mevel P, et al
    Effects of inspiratory muscle training on dyspnoea in severe COPD patients during pulmonary rehabilitation: controlled randomised trial.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available

  17. SCHULTZ K, Jelusic D, Wittmann M, Kramer B, et al
    Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available

  18. MOKOKA MC, McDonnell MJ, MacHale E, Cushen B, et al
    Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy. Results from a systematic literature review and modelling study.
    Eur Respir J. 2019 Mar 7. pii: 13993003.02161-2018.
    PubMed     Text format     Abstract available

  19. DE VRIES R, Dagelet YWF, Spoor P, Snoey E, et al
    Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available

  20. STEURER-STEY C, Dalla Lana K, Braun J, Ter Riet G, et al
    Effects of the "Living well with COPD" intervention in primary care: a comparative study.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available

  21. ROSE L, Istanboulian L, Carriere L, Thomas A, et al
    Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD(+)): a randomised controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available

  22. KESSLER R, Casan-Clara P, Koehler D, Tognella S, et al
    COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available

  23. ALCAZAR-NAVARRETE B, Ruiz Rodriguez O, Conde Baena P, Romero Palacios PJ, et al
    Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    J Allergy Clin Immunol

  24. POOLE JA, Barnes CS, Demain JG, Bernstein JA, et al
    Impact of weather and climate change with indoor and outdoor air quality in asthma.
    J Allergy Clin Immunol. 2019 Feb 28. pii: S0091-6749(19)30281.
    PubMed     Text format     Abstract available


    J Appl Physiol (1985)

  25. SORKNESS RL, Kienert C, O'Brien MJ, Fain SB, et al
    Compressive Air-trapping in Asthma: Effects of Age, Sex, and Severity.
    J Appl Physiol (1985). 2019 Mar 7. doi: 10.1152/japplphysiol.00924.2018.
    PubMed     Text format     Abstract available


    J Asthma

  26. KORDIT DS, Reznik M, Leu CS, Jariwala SP, et al
    Longitudinal trends in asthma emergency department visits, pollutant and pollen levels, and weather variables in the Bronx from 2001-2008.
    J Asthma. 2019 Mar 8:1-8. doi: 10.1080/02770903.2019.1585871.
    PubMed     Text format     Abstract available


    J Pediatr

  27. VO P, Koppel C, Espinola JA, Mansbach JM, et al
    Vitamin D Status at the Time of Hospitalization for Bronchiolitis and Its Association with Disease Severity.
    J Pediatr. 2018;203:416-422.
    PubMed     Text format     Abstract available

  28. ABRAMS EM, Becker AB, Szefler SJ
    Use of Oral Corticosteroids in the Wheezy Toddler.
    J Pediatr. 2018;201:16-20.
    PubMed     Text format    


    Lancet Respir Med

  29. SAGLANI S, Bush A, Carroll W, Cunningham S, et al
    Biologics for paediatric severe asthma: trick or TREAT?
    Lancet Respir Med. 2019 Feb 26. pii: S2213-2600(19)30045.
    PubMed     Text format    

  30. BURKI TK
    Asthma control: learning from Finland's success.
    Lancet Respir Med. 2019;7:207-208.
    PubMed     Text format    

  31. FANG L, Gao P, Bao H, Tang X, et al
    Chronic obstructive pulmonary disease in China: a nationwide prevalence study.
    Lancet Respir Med. 2018;6:421-430.
    PubMed     Text format     Abstract available

  32. HAWCUTT DB, Francis B, Carr DF, Jorgensen AL, et al
    Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study.
    Lancet Respir Med. 2018;6:442-450.
    PubMed     Text format     Abstract available


    PLoS One

  33. MEHANNA N, Mohamed N, Wordofa M, Abera D, et al
    Allergy-related disorders (ARDs) among Ethiopian primary school-aged children: Prevalence and associated risk factors.
    PLoS One. 2018;13:e0204521.
    PubMed     Text format     Abstract available

  34. TENG F, Ye H, Xue T
    Predictive value of neutrophil to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease.
    PLoS One. 2018;13:e0204377.
    PubMed     Text format     Abstract available

  35. JANUSZEK R, Dziewierz A, Siudak Z, Rakowski T, et al
    Chronic obstructive pulmonary disease and periprocedural complications in patients undergoing percutaneous coronary interventions.
    PLoS One. 2018;13:e0204257.
    PubMed     Text format     Abstract available

  36. LASTRUCCI V, D'Arienzo S, Collini F, Lorini C, et al
    Diagnosis-related differences in the quality of end-of-life care: A comparison between cancer and non-cancer patients.
    PLoS One. 2018;13:e0204458.
    PubMed     Text format     Abstract available


    Respir Med

  37. FERRI S, Crimi C, Heffler E, Campisi R, et al
    Vitamin D and disease severity in bronchiectasis.
    Respir Med. 2019;148:1-5.
    PubMed     Text format     Abstract available

  38. FARAH CS, Badal T, Reed N, Rogers PG, et al
    Mepolizumab improves small airway function in severe eosinophilic asthma.
    Respir Med. 2019;148:49-53.
    PubMed     Text format     Abstract available

  39. SASSO F, Izard M, Beneteau T, Rakotozandry T, et al
    18-year evolution of asthma and allergic diseases in French urban schoolchildren in relation to indoor air pollutant levels.
    Respir Med. 2019;148:31-36.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: